A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
Open Access
- 15 April 2021
- Vol. 9 (4), 389
- https://doi.org/10.3390/vaccines9040389
Abstract
COVID-19 is an ongoing pandemic caused by the highly infectious coronavirus SARS-CoV-2 that is engaging worldwide scientific research to find a timely and effective eradication strategy. Great efforts have been put into anti-COVID-19 vaccine generation in an effort to protect the world population and block SARS-CoV-2 spread. To validate the protective efficacy of the vaccination campaign and effectively control the pandemic, it is necessary to quantify the induction of neutralizing antibodies by vaccination, as they have been established to be a correlate of protection. In this work, a SARS-CoV-2 pseudovirus neutralization assay, based on a replication-incompetent lentivirus expressing an adapted form of CoV-2 S protein and an ACE2/TMPRSS2 stably expressing cell line, has been minimized in terms of protocol steps without loss of accuracy. The goal of the present simplified neutralization system is to improve SARS-CoV-2 vaccination campaign by means of an easy and accessible approach to be performed in any medical laboratory, maintaining the sensitivity and quantitative reliability of classical serum neutralization assays. Further, this assay can be easily adapted to different coronavirus variants by simply modifying the pseudotyping vector.This publication has 32 references indexed in Scilit:
- The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particlesJournal of General Virology, 2016
- Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia FormationPLOS ONE, 2013
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2Journal of Virology, 2010
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entryProceedings of the National Academy of Sciences of the United States of America, 2008
- Plasma Membrane Is the Site of Productive HIV-1 Particle AssemblyPLoS Biology, 2006
- High Guanine and Cytosine Content Increases mRNA Levels in Mammalian CellsPLoS Biology, 2006
- Retroviral Vectors Pseudotyped with Severe Acute Respiratory Syndrome Coronavirus S ProteinJournal of Virology, 2004
- Codon bias and heterologous protein expressionTrends in Biotechnology, 2004
- Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from SingaporeHuman Pathology, 2003